Canada markets open in 4 hours 26 minutes
  • S&P/TSX

    21,077.35
    -85.30 (-0.40%)
     
  • S&P 500

    4,701.21
    +14.46 (+0.31%)
     
  • DOW

    35,754.75
    +35.32 (+0.10%)
     
  • CAD/USD

    0.7885
    -0.0021 (-0.26%)
     
  • CRUDE OIL

    72.12
    -0.24 (-0.33%)
     
  • BTC-CAD

    62,451.53
    -1,576.04 (-2.46%)
     
  • CMC Crypto 200

    1,287.37
    -17.74 (-1.36%)
     
  • GOLD FUTURES

    1,782.30
    -3.20 (-0.18%)
     
  • RUSSELL 2000

    2,271.71
    +17.92 (+0.80%)
     
  • 10-Yr Bond

    1.5090
    0.0000 (0.00%)
     
  • NASDAQ futures

    16,357.25
    -35.00 (-0.21%)
     
  • VOLATILITY

    20.26
    -1.63 (-7.45%)
     
  • FTSE

    7,335.26
    -1.79 (-0.02%)
     
  • NIKKEI 225

    28,725.47
    -135.15 (-0.47%)
     
  • CAD/EUR

    0.6965
    -0.0002 (-0.03%)
     

Decreasing 30-day hospital revisits in patients with COVID-19

·3 min read

Study in November2021 issue of The Joint Commission Journal on Quality and Patient Safety

OAKBROOK TERRACE, Ill., Oct. 28, 2021 (GLOBE NEWSWIRE) -- The COVID-19 pandemic has resulted in an unprecedented surge in health care resource utilization. To accommodate the influx of patients, health care systems have needed to alter their workflows, staffing allocation, and use of space and equipment, while simultaneously managing significant concurrent logistical and financial challenges.

As a result, COVID-19 may have affected the preventability of 30-day hospital revisits, including readmissions and emergency department (ED) visits without admission. A new study in the November 2021 issue of The Joint Commission Journal on Quality and Patient Safety, “Preventability of 30-Day Hospital Revisits Following Admission with COVID-19 at an Academic Medical Center,” identified common contributing factors and recommended interventions to decrease future revisits among patients with COVID-19.

The study identified patients with a 30-day revisit following hospital discharge at an academic medical center. Findings showed 13.2% of COVID-19 hospitalizations resulted in a 30-day revisit. Of these, more than a quarter were potentially preventable. The top five contributing factors included:

  • Patient/caregiver misunderstanding of the discharge medication (25% of revisits)

  • Inappropriate choice of discharge location (25% of revisits)

  • Inadequate treatment of medical conditions (15% of revisits)

  • Discharge without needed procedure (15% of revisits)

  • Patient discharged too soon (15% of revisits)

The study authors also provided recommended interventions to reduce hospital revisits among patients with COVID-19, including improved self-management at discharge to ensure the patient and caregiver(s) understand and can follow through with the discharge plan, as well as improved clarity, timeliness and availability of information provided at discharge. Another recommended intervention was to provide more complete communication of information such as high-quality, comprehensive discharge documentation. The study authors believe the interventions could be applied to reduce revisits in the future, in both pandemic and non-pandemic conditions.

“This study emphasizes that among patients with COVID-19, the vast majority of readmissions still fall under broad categories of risk factors that plagued our national health care system before the pandemic,” adds an accompanying editorial by Kendall G. Fancher, MD, and Mark V. Williams, MD. “Hospitals and clinicians must continue to review known fundamental risk factors for high-risk readmissions and address them.”

Also featured in the November issue:

For more information, visit The Joint Commission Journal on Quality and Patient Safety website.

Note for editors
The article is “Preventability of 30-Day Hospital Revisits Following Admission with COVID-19 at an Academic Medical Center” by Daniel Taupin, MD, MHQS, CPPS; Timothy S. Anderson, MD, MAS; Elisabeth A. Merchant, MD; Andrew Kapoor, MD, MSc; Lauge Sokol-Hessner, MD; Julius J. Yang, MD, PhD; Andrew D. Auerbach, MD, MPH; Jennifer P. Stevens, MD, MS; and Shoshana J. Herzig, MD, MPH. The article appears in The Joint Commission Journal on Quality and Patient Safety, volume 47, number 11 (November 2021), published by Elsevier.

The Joint Commission Journal on Quality and Patient Safety
The Joint Commission Journal on Quality and Patient Safety (JQPS) is a peer-reviewed journal providing health care professionals with innovative thinking, strategies and practices in improving quality and safety in health care. JQPS is the official journal of The Joint Commission and Joint Commission Resources, Inc. Original case studies, program or project reports, reports of new methodologies or the new application of methodologies, research studies, and commentaries on issues and practices are all considered.

Media Contact:
Katie Bronk
Corporate Communications
(630) 792-5175
kbronk@jointcommission.org

View the multimedia news release


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting